Document Detail


Osteonecrosis in the rheumatoid femoral head.
MedLine Citation:
PMID:  9733445     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To define the prevalence and pathological spectrum of femoral head osteonecrosis in patients with rheumatoid arthritis (RA) and to correlate its presence with disease related clinical and therapeutic factors. METHODS: A total of 545 primary total hip arthroplasties performed in 507 patients with RA were identified. A historical review of each patient's rheumatoid disease and treatment as well as pathological review of each femoral head specimen was performed. RESULTS: Osteonecrosis was identified in 66 specimens (12.1%) in one of 2 discrete forms. Thirty-two specimens (5.9%) contained classic subchondral avascular necrosis. Thirty-four specimens (6.2%) contained osteonecrosis in association with degenerative changes (within regions of sclerotic and eburnated subchondral bone), but not classic avascular necrosis. Remaining femoral head specimens were characterized by inflammatory arthritis (431 specimens) or degenerative joint disease (48 specimens). Corticosteroid therapy was used in 81% of patients with avascular necrosis and 68% with degenerative osteonecrosis. This was significantly greater prevalence than in patients without osteonecrosis (33%). Average daily prednisone dosage was 8 mg and no association between dosage and the presence of osteonecrosis was identified. No correlation between pathological findings and clinical disease severity was identified. In 5 of 27 specimens showing classic avascular necrosis and 11 of 34 containing degenerative osteonecrosis, no steroid treatment had been administered. CONCLUSION: Femoral head osteonecrosis is present in about 12% of patients with RA at hip arthroplasty, and occurs in 2 forms -- classic avascular necrosis and degenerative necrosis. Both forms are significantly associated with corticosteroid use. "Low dose" therapy does not protect patients against the development of osteonecrosis. Additionally, baseline prevalence of osteonecrosis of about 3% occurs in the absence of steroid use and may be related to the underlying inflammatory diseases. Despite its association with osteonecrosis the net effect of corticosteroid therapy on the natural history of rheumatoid hip disease remains unclear.
Authors:
S J Zabinski; T P Sculco; E F Dicarlo; M Rivelis
Related Documents :
3151145 - Hla-alloantigen associations in greek patients with sjögren's syndrome.
3730735 - Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of co...
11860615 - Rheumatoid arthritis, gold therapy, contact allergy and blood cytokines.
20711095 - Central diabetes insipidus induced by tuberculosis in a rheumatoid arthritis patient.
20116815 - Late association of hyperparathyroidism in septic patients with multiple organ failure.
21950985 - Clinical, electrophysiological, and mri findings in patients with cerebellar ataxia and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  25     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-19     Completed Date:  1998-11-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1674-80     Citation Subset:  IM    
Affiliation:
The Hospital for Special Surgery, New York, New York 10021, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthritis, Rheumatoid / complications*,  pathology,  surgery
Arthroplasty, Replacement, Hip
Female
Femur Head Necrosis / epidemiology,  etiology*,  pathology
Humans
Incidence
Male
Middle Aged
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adenovirus mediated gene delivery to the joints of guinea pigs.
Next Document:  Forefoot deformity, pain, and mobility in rheumatoid and nonarthritic subjects.